美國(guó)路明克斯 Luminex  www.luminexcorp.com
Luminex公司成立于1995年，總部位于美國(guó)德克薩斯州的奧斯汀，于2000年在美國(guó)納斯達(dá)克上市，公司的xMAP（multi-analyte profiling）開(kāi)放式結(jié)構(gòu)平臺(tái)，在流式細(xì)胞技術(shù)、ELISA技術(shù)和芯片技術(shù)基礎(chǔ)上，有機(jī)地整和了編碼微球、激光技術(shù)、應(yīng)用流體學(xué)、最新的高速數(shù)字信號(hào)處理器和計(jì)算機(jī)運(yùn)算法則，能帶來(lái)快速、準(zhǔn)確、經(jīng)濟(jì)的分析結(jié)果，廣泛應(yīng)用于免疫分析、核酸研究、酶學(xué)分析、受體和配體識(shí)別分析等研究得到各權(quán)威機(jī)構(gòu)和醫(yī)學(xué)界高度認(rèn)可，是臨床診斷領(lǐng)域以及生命科學(xué)研究中的一大熱點(diǎn)。
“液態(tài)芯片”xMAP技術(shù)是美國(guó)納斯達(dá)克上市公司Luminex研制出的后基因組時(shí)代技術(shù)平臺(tái)。Luminex公司是納斯達(dá)克生物技術(shù)指數(shù)股的成員，被福布斯（Forbes）雜志評(píng)為２００１年美國(guó)第二活躍的生物技術(shù)公司。

Luminex Corporation was incorporated in May 1995 and began commercial production of our first generation system in 1997. Luminex® (NASDAQ: LMNX) develops, manufactures and markets innovative biological testing technologies with applications throughout the life science and diagnostic industries. The company’s open-architecture xMAP® technology enables large numbers of biological tests (bioassays) to be conducted and analyzed quickly, cost-effectively and accurately. 
Systems using xMAP technology perform discrete bioassays on the surface of color-coded beads known as microspheres, which are then read in a compact analyzer. Using lasers and high-speed digital-signal processors, the analyzer simultaneously identifies the bioassay and measures the results, all in real time.
Luminex Vision Statement
Worldwide Leader in Multiplexed Solutions